Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Exact Sciences Corporation EXAS
$78.97
+$0.91 (1.15%)
На 18:00, 12 мая 2023
+32.28%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
14043158345.00000000
-
week52high
80.75
-
week52low
29.27
-
Revenue
2084279000
-
P/E TTM
-19
-
Beta
1.41557000
-
EPS
-3.52000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Credit Suisse | Outperform | 25 авг 2022 г. | |
| Piper Sandler | Overweight | Overweight | 18 авг 2022 г. |
| Craig-Hallum | Buy | Buy | 03 авг 2022 г. |
| Cowen & Co. | Outperform | Outperform | 03 авг 2022 г. |
| BTIG | Buy | Buy | 03 авг 2022 г. |
| Craig-Hallum | Hold | Buy | 19 окт 2022 г. |
| Piper Sandler | Neutral | Neutral | 14 ноя 2022 г. |
| Raymond James | Outperform | Outperform | 08 ноя 2022 г. |
| BTIG | Buy | Buy | 07 ноя 2022 г. |
| Raymond James | Market Perform | Outperform | 18 янв 2023 г. |
| SVB Leerink | Outperform | Outperform | 12 янв 2023 г. |
| SVB Leerink | Outperform | Outperform | 06 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Condella Sarah | D | 84090 | 1000 | 01 февр 2023 г. |
| Doyle James Edward | D | 0 | 5477 | 13 янв 2023 г. |
| Doyle James Edward | A | 53913 | 5477 | 13 янв 2023 г. |
| Condella Sarah | D | 85090 | 1000 | 09 янв 2023 г. |
| COWARD D SCOTT | A | 24342 | 7780 | 03 янв 2023 г. |
| Cunningham Everett | D | 18654 | 16872 | 12 окт 2022 г. |
| Cunningham Everett | D | 15002 | 15003 | 11 окт 2022 г. |
| Cunningham Everett | D | 40007 | 20003 | 11 окт 2022 г. |
| Cunningham Everett | A | 35526 | 15003 | 11 окт 2022 г. |
| Cunningham Everett | A | 20523 | 20003 | 11 окт 2022 г. |
Новостная лента
Why Exact Sciences Stock Roared Higher This Week
The Motley Fool
11 мая 2023 г. в 14:58
Exact Sciences reported first-quarter earnings last Tuesday. Thanks to multiple positive developments, investors bid up the biotech's shares this week.
Why Shares of Exact Sciences Rose on Wednesday
The Motley Fool
10 мая 2023 г. в 14:42
Several analysts upgraded their price targets for Exact Sciences. The company saw revenue rise by 24% year over year.
EXAS Stock Earnings: Exact Sciences Beats EPS, Revenue Estimates
InvestorPlace
09 мая 2023 г. в 16:24
Exact Sciences (NASDAQ: EXAS ) reported results for the first quarter of 2023. Exact Sciences reported a loss per share of 42 cents.
Exact Sciences Posts Its 11th Consecutive Sales Beat As It Targets 'The Most Preventable' Cancer
Investors Business Daily
09 мая 2023 г. в 16:05
Exact Sciences crushed first-quarter expectations late Tuesday and raised its outlook for the year. The news is likely to stoke EXAS stock.
3 Stocks That AI Predicts Will Outperform the Market
InvestorPlace
04 мая 2023 г. в 07:15
Finding stocks that will outperform the market is a daunting task in any market. It's challenging when every sector in the S&P 500 is getting hammered.